KFF Health News January 6, 2026
Paula Span

Year after year, Mary Bucklew strategized with a nurse practitioner about losing weight. “We tried exercise,” like walking 35 minutes a day, she recalled. “And 39,000 different diets.”

But 5 pounds would come off and then invariably reappear, said Bucklew, 75, a public transit retiree in Ocean View, Delaware. Nothing seemed to make much difference — until 2023, when her body mass index slightly exceeded 40, the threshold for severe obesity.

“There’s this new drug I’d like you to try, if your insurance will pay for it,” the nurse practitioner advised. She was talking about Ozempic.

Medicare covered it for treating Type 2 diabetes but not for weight loss, and it cost more than $1,000 a month out-of-pocket. But to...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider
Daniel Kraft: “The future of healthcare depends on our mindset”
What Home-Based Care Consumers Really Want
STAT+: 9 influencers shaping health information online, for better or worse
Serious Illness Care Runs on Caregivers — It’s Time to Act Like It
Why AI’s Productivity Promise Falls Apart Without Human Expertise

Share Article